Home › Research › Down syndrome and Alzheimer's
Expression of APP in brains of transgenic mice containing the entire human APP gene
Buxbaum JD, Christensen JL, Ruefli AA, Greengard P, Loring JF.. Biochemical and biophysical research communications, 1993-12-01
Topic: Brain proteins, microglia and lab models
Plain-language summary
A major component of amyloid deposits found in Alzheimer disease and Down syndrome is the beta/A4 peptide, which is derived from the Alzheimer amyloid protein precursor (APP). Recent evidence indicates that increases in APP expression and/or beta/A4 peptide accumulation may underlie the amyloidosis characteristic of these diseases. In the present study, transgenic mice carrying the entire human APP gene were studied for expression of human APP. Significant expression of human APP protein was observed in these animals, and this expression paralleled the expression of endogenous APP. These results, which represent a first demonstration of significant human APP expression in transgenic animals, support the use of such animals to study human APP expression and processing in vivo and possibly as models for the amyloidosis associated with Alzheimer disease.
What this study adds
Evidence grade: Low
Mice carrying the entire human amyloid precursor protein gene expressed the human protein in their brains. This is an early animal study supporting use of such mice to study amyloidosis, not a treatment or cure.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Buxbaum, J. D., Christensen, J. L., Ruefli, A. A., Greengard, P., & Loring, J. F. (1993). Expression of APP in brains of transgenic mice containing the entire human APP gene. Biochemical and biophysical research communications. https://doi.org/10.1006/bbrc.1993.2527
Vancouver
Buxbaum JD, Christensen JL, Ruefli AA, Greengard P, Loring JF. Expression of APP in brains of transgenic mice containing the entire human APP gene. Biochemical and biophysical research communications. 1993. doi:10.1006/bbrc.1993.2527. PMID: 8267600.
BibTeX
@article{buxbaum1993-8267600,
author = {Buxbaum, J. D. and Christensen, J. L. and Ruefli, A. A. and Greengard, P. and Loring, J. F.},
title = {{Expression of APP in brains of transgenic mice containing the entire human APP gene}},
journal = {Biochemical and biophysical research communications},
year = {1993},
doi = {10.1006/bbrc.1993.2527},
pmid = {8267600},
url = {https://doi.org/10.1006/bbrc.1993.2527}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Recent evidence indicates that increases in APP expression and/or beta/A4 peptide accumulation may underlie the amyloidosis characteristic of these diseases.
- Significant expression of human APP protein was observed in these animals, and this expression paralleled the expression of endogenous APP.
- These results, which represent a first demonstration of significant human APP expression in transgenic animals, support the use of such animals to study human APP expression and processing in vivo and possibly as models for the amyloidosis associated with Alzheimer disease.
Why it matters
Mice carrying the entire human amyloid precursor protein gene expressed the human protein in their brains. This is an early animal study supporting use of such mice to study amyloidosis, not a treatment or cure.
Study details
- Evidence strengthLow
How this study scored 37/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Biochemical and biophysical research communications) |
| Journal's citation record | 3 / 4 | Biochemical and Biophysical Research Communications: journal h-index 393 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 1993 — older than 20 years, still counted |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Laboratory or animal study (title names “transgenic”) — scores zero |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 4 / 7 | Cited 63 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 1.8 citations a year over 35 year(s) since 1993 |
| Impact for its field and year | 2 / 6 | Cited 2.9× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 2 / 6 | Cited by 4 other studies in this library |
| Still being cited | 0 / 4 | Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Jeanne F. Loring: h-index 61 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Rockefeller University: institution h-index 1,200 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 8267600) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 37 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Later studies that cite this one
4 studies in the alzhub library list this one in their references.
Related studies in Down syndrome and Alzheimer's from nearby years
Also tagged “down”
527 studies in the library carry the topic tag “down”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 527 tagged studies.